The Raphael Recanati Genetic Institute, Rabin Medical Center, Petah Tikva 49100, Israel.
School of Medicine, Tel Aviv University, Tel Aviv P.O.B 39040, Israel.
Genes (Basel). 2023 Sep 23;14(10):1854. doi: 10.3390/genes14101854.
Alport syndrome is a hereditary disorder caused by pathogenic variants in the COL4A gene, which can be inherited in an autosomal recessive, dominant, or X-linked pattern. In the Bukharian Jewish population, no founder pathogenic variant has been reported in COL4A4.
The cohort included 38 patients from 22 Bukharian Jewish families with suspected Alport syndrome who were referred the nephrogenetics clinic between 2012 and 2022. The study collected demographic, clinical, and genetic data from electronic medical records, which were used to evaluate the molecular basis of the disease using Sanger sequencing, and next-generation sequencing.
Molecular diagnosis was confirmed in 20/38 patients, with each patient having at least one of the three disease-causing COL4A4 variants detected: c.338G<A (p.Gly113Asp), c.3022G>A (p.Gly1008Arg), and c.871-6T>C. In addition, two patients were obligate carriers. Overall, there were 17 heterozygotes, 2 compound heterozygotes, and 3 homozygotes. Each variant was detected in more than one unrelated family. All patients had hematuria with/without proteinuria at referral, and the youngest patient with proteinuria (age 5 years) was homozygous for the c.338G>A variant. End-stage renal disease was diagnosed in two patients at the age of 38 years, a compound heterozygote for c.338G>A and c.871-6T>C. Hearing deterioration was detected in three patients, the youngest aged 40 years, all of whom were heterozygous for c.338G>A.
This study unveils three novel disease-causing variants, c.3022G>A, c.871-6T>C, and c.338G>A, in the COL4A4 gene that are recurrent among Jews of Bukharian ancestry, and cause Alport syndrome in both dominant and recessive autosomal inheritance patterns.
Alport 综合征是一种遗传性疾病,由 COL4A 基因的致病性变异引起,可呈常染色体隐性、显性或 X 连锁遗传方式。在布哈拉犹太人群体中,尚未报道 COL4A4 中的致病突变。
该队列纳入了 2012 年至 2022 年间在肾脏遗传学门诊就诊的 22 个布哈拉犹太家族的 38 名疑似 Alport 综合征患者。研究人员从电子病历中收集了人口统计学、临床和遗传学数据,用于通过 Sanger 测序和下一代测序评估疾病的分子基础。
在 38 名患者中,20 名患者的分子诊断得到了确认,每位患者至少检测到三种致病 COL4A4 变异之一:c.338G<A(p.Gly113Asp)、c.3022G>A(p.Gly1008Arg)和 c.871-6T>C。此外,还有 2 名患者为纯合携带者。总的来说,有 17 名杂合子、2 名复合杂合子和 3 名纯合子。每个变异都在不止一个无血缘关系的家族中被检测到。所有患者在就诊时均有血尿伴/不伴蛋白尿,最年轻的蛋白尿患者(5 岁)为 c.338G>A 纯合子。2 名患者在 38 岁时被诊断为终末期肾病,为 c.338G>A 和 c.871-6T>C 的复合杂合子。有 3 名患者出现听力下降,最年轻的 40 岁,均为 c.338G>A 的杂合子。
本研究揭示了三种新的致病变异,c.3022G>A、c.871-6T>C 和 c.338G>A,在布哈拉犹太人群体中是反复出现的,可导致显性和常染色体隐性遗传模式下的 Alport 综合征。